⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 18 in last 7 days 🍎 Food: 180 in last 7 days 🧸 Products: 48 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 4 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT April 17, 2026

Milrinon Carino 1 mg/ml Injektions- oder Infusionslösung 1 mg/ml (Injektions-/Infusionslösung)

📷 Wikipedia: Milrinone · Source
Milrinon Carino 1 mg/ml Injektions- oder Infusionslösung 1 mg/ml (Injektions-/Infusionslösung)
📷 Wikipedia: Milrinone · Source
Parallel export ban active.
✅
Resolved by agency
The issuing agency has confirmed this medicine alert is over — the underlying issue was addressed. Originally reported 40 days ago.
📈 Timeline
3 days in total
May 18, 2026 May 21, 2026

What is this? This is a heart medicine called milrinone. It comes in a small bottle or tube for injections or drips.

What's happening? The medicine is hard to find right now. It ran out on April 17 and will come back on May 29.

Does this affect me? If you take this medicine, you may not be able to get it until late May.

What should I do? Ask your pharmacist or doctor for help. They can suggest another safe option.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
MILRINON
Agency-published detail

🚫 Parallel export ban active · ATC: C01CE02 · Reason: Erhöhter Mehrbedarf · Marketing authorisation holder: Carinopharm GmbH, Unter Den Tannen 6, 31036 Eime, Federal Republic of Germany · Affected packs: 5 Stück Schachtel, Ampulle [Nicht verfügbar, since 2026-04-17, resupply 2026-05-29]

First published
April 17, 2026
Last refreshed by us
6 days ago
Severity (as classified)
Medium
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

High AT 3 months ago

Asicor 1 mg/ml Konzentrat zur Herstellung einer Infusionslösung 1 mg/ml (Konzentrat zur Herstellung einer Infusionslösung)

Asicor 1 mg/ml concentrate for preparing an infusion solution 1 mg/ml (concentrate for preparing an infusion solution)
High AT 5 months ago

Milrinon Hikma 1 mg/ml Injektionslösung 1 mg/ml (Injektionslösung)

Parallel export is banned. This medicine is in short supply. It is not available. Resupply is expected on 30 June 2026.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Milrinon Carino 1 mg/ml Injektions- oder Infusionslösung 1 mg/ml (Injektions-/Infusionslösung). Parallel export ban active.
▸ When was this alert issued?
This alert was issued on April 17, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.